Search research articles
Contact Us
Filters
Showing results (131-140 of 138) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 138 results.
Atherosclerosis
|
August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial
S E Humphries, L A Luong, P J Talmud, et al.
The New England Journal of Medicine
|
November 12, 1987
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
M H Frick, O Elo, K Haapa, et al.
European Heart Journal
|
October 1, 1987
The Helsinki Heart Study: basic design and randomization procedure
M Mänttäri, O Elo, M H Frick, et al.
The American Journal of Cardiology
|
May 29, 1987
Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension
M H Frick, D A Cox, P Himanen, et al.
JAMA
|
August 5, 1988
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
V Manninen, M O Elo, M H Frick, et al.
The Journal of Clinical Investigation
|
April 16, 1998
Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators
E Tahvanainen, M Syvanne, M H Frick, et al.
Circulation
|
November 10, 1998
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol
M Syvänne, M S Nieminen, M H Frick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 14, 1999
Heart rate variability and progression of coronary atherosclerosis
H V Huikuri, V Jokinen, M Syvänne, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 138) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 138 results.
Atherosclerosis
|
August 12, 1998
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial
S E Humphries, L A Luong, P J Talmud, et al.
The New England Journal of Medicine
|
November 12, 1987
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
M H Frick, O Elo, K Haapa, et al.
European Heart Journal
|
October 1, 1987
The Helsinki Heart Study: basic design and randomization procedure
M Mänttäri, O Elo, M H Frick, et al.
The American Journal of Cardiology
|
May 29, 1987
Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension
M H Frick, D A Cox, P Himanen, et al.
JAMA
|
August 5, 1988
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
V Manninen, M O Elo, M H Frick, et al.
The Journal of Clinical Investigation
|
April 16, 1998
Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators
E Tahvanainen, M Syvanne, M H Frick, et al.
Circulation
|
November 10, 1998
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol
M Syvänne, M S Nieminen, M H Frick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 14, 1999
Heart rate variability and progression of coronary atherosclerosis
H V Huikuri, V Jokinen, M Syvänne, et al.
Page
of 14